LRP5通过调节MAPK/p53/cdc2通路来增强质瘤细胞的增殖
Ying-Yi Feng1,2, Xin Jin3, Min-Xuan Pan1,2,4,5
1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
International journal of medical sciences
|February 24, 2025
概括
低密度脂蛋白受体5 (LRP5) 通过影响细胞周期G2/M过渡和MAPK/p53/cdc2通路,促进质瘤细胞增殖. LRP5是潜在的分子点,用于结质瘤的诊断和治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤是一种恶性脑瘤,治疗选择有限,预后不佳.
- 低密度脂蛋白受体5 (LRP5) 与各种癌症有关,但其在质瘤中的作用尚不清楚.
- 了解LRP5的功能对于开发新的质瘤疗法至关重要.
研究的目的:
- 研究LRP5在质瘤细胞增殖中的作用.
- 阐明LRP5对质瘤影响的分子机制.
- 评估LRP5作为质瘤的潜在诊断和治疗点.
主要方法:
- 在质瘤组织中对LRP5表达的生物信息分析.
- 使用临床质瘤样本进行验证.
- 通过RNA干扰来降低质瘤细胞中LRP5表达的调节,然后进行增殖试验,流细胞计和西式涂抹.
主要成果:
- 在质瘤组织中,LRP5的升高调节,在质母细胞瘤亚型中存在显著差异.
- 降低LRP5的调节抑制了结质瘤细胞的增殖,殖民地形成,并诱导G2/M细胞循环停止.
- LRP5影响MAPK/p53/cdc2通路,增加p-p53,p21和p-cdc2水平,并抑制JNK和p38MAPK的酸化.
结论:
- 通过调节G2/M细胞周期过渡和激活MAPK/p53/cdc2通路,LRP5促进质瘤的扩散.
- LRP5代表了一种有前途的分子标,用于质瘤的诊断和治疗.
- 作为LRP5抗剂的DKK-1复制了在LRP5下调时观察到的抑制作用.
更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.7K
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K